Veracyte, Inc. (VCYT) stock analysis
VCYT · Veracyte, Inc.
Latest recorded price: USD 24.01
Model-estimated fair value: USD 13.36. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Diagnostics & Research
At $24.01, VCYT trades 79.8% above the model's base-case value of $13.36. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $10.68 in the conservative case and $16.65 in the optimistic case, with a valuation confidence score of 75/100. Fiscal 2025 figures: revenue growth 20.4%, free cash flow margin 24.5%, ROIC 4.1%. The model does not flag any risk signals for this company.
Similar companies in Healthcare
- Waters Corporation (WAT)
- GeneDx Holdings Corp. (WGS)
- Agilent Technologies, Inc. Common Stock (A)
- Adaptive Biotechnologies Corporation (ADPT)
- CareDx, Inc. - Common Stock (CDNA)
- Charles River Laboratories International, Inc. (CRL)
- Castle Biosciences, Inc. (CSTL)
- Quest Diagnostics Incorporated Common Stock (DGX)